Doripenem how supplied

Revision as of 22:15, 5 January 2014 by Gerald Chi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Doripenem
DORIBAX® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

How Supplied

DORIBAX® is supplied as single use type 1 clear glass vials containing 250 mg or 500 mg (on an anhydrous basis) of sterile doripenem powder. Vials are packaged individually and in cartons containing 10 vials.

  • NDC: 50458-401-01 – 500 mg/vial, single vial
  • NDC: 50458-401-02 – 500 mg/vial, 10 vials/carton
  • NDC: 50458-402-01 – 250 mg/vial, single vial
  • NDC: 50458-402-02 – 250 mg/vial, 10 vials/carton

Storage of DORIBAX® vials

DORIBAX® should be stored at 25°C (77°F); excursions permitted to 15°–30°C (59° to 86°F) [refer to USP controlled room temperature].[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022106s014lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.